内科学硕士专业
Master’s Program in Internal Medicine
导师介绍 Supervisor Profiles
谢伟基 Weiji Xie
邮箱及联系电话：13005204031@163.com,
86-0754-88915607, 86-13005204031 Email & Contact Number：13005204031@163.com,
86-0754-88915607, 86-13005204031
研究方向：
肾小球疾病，急、慢性肾衰竭，慢性肾脏病心血管并发症，腹膜透析和血液透析。 Research Field:
Glomerular disease, acute and chronic renal failure, chronic renal disease and cardiovascular complications, peritoneal dialysis and hemodialysis.
导师简介：
目前兼任广东省肾脏病健康教育学会副主委、广东省医师协会肾脏病分会常委， 广东省医学会肾脏病分会委员，汕头大学医学院学报审稿专家。 1985 年 7 月在 广东医学院医疗系本科毕业并获得学士学位，毕业后分配到梅州市人民医院内科 工作。1989 年 9 月-1990 年 9 月在中山大学第一附属医院肾内科和人工肾科进修 学习， 1993 年 10 月调至汕头大学医学院第二附属医院肾内科工作，2002 年 11 月被聘为肾内科主任医师， 一直从事肾脏疾病的临床、科研和教学工作，2012 年 12 月被任命为汕头大学医学院第二附属医院肾内科主任至今。 2016 年获得 汕头市科技进步二等奖一项，近 5 年来参与发表论文 20 篇，其中国内核心期刊 14 篇，SCI 6 篇，参与科研立项 4 项，其中省级课题 3 项。
Weiji Xie, professor, chief physician, is also the vice chairman of Guangdong Kidney Disease Health Education Society, the standing committee member of Kidney Disease Branch of Guangdong Medical Doctor Association, the committee member of Kidney Disease Branch of Guangdong Medical Association, and the peer reviewer of the Journal of Shantou University Medical College. Professor Xie graduated from the medical department of Guangdong Medical College and obtained a bachelor's degree in July 1985. After graduation, he was assigned to the internal medicine of Meizhou people's hospital. From September 1989 to September 1990, he advanced professional skills in the Department of Nephrology and artificial kidney of the First Affiliated Hospital of Sun Yat Sen University. In October 1993, he was transferred to the Department of Nephrology of the Second Affiliated Hospital of Shantou University
Medical College. In November 2002, he was appointed as the chief physician of Nephrology and has been engaged in clinical, scientific research and teaching of renal diseases. Since December 2012, he has been nominated to the director of Nephrology Department of the Second Affiliated Hospital of Shantou University Medical College. In 2016, he won the municipal class of the second award of scientific and technological advancement. In the past five years, he has participated in publishing 20 domestic and foreign papers and acquired 4 scientific research projects, including 3 Provincial-level projects.
肾脏病学 Nephrology
本学科（肾脏病学）始终坚持以临床重大科学问题为中心的，临床和基础研究紧 密结合的转化医学研究，重点探讨常见肾脏疾病的发病机制、综合防治作和预防 工作。并结合中国肾脏病的实际情况， 以 IgA 肾病、狼疮性肾炎、腹膜透析为 优先研究领域；同时，积极开展慢性肾脏病的流行病学调查，针对危险因素的社 区干预，为预防慢性肾脏病和减少尿毒症的发生率为重要目标，并为政府防治慢 性肾脏病提供科学依据。
汕头大学医学院第二附属医院肾内科现有正高职称 1 人，副高职称 2 人，硕士 导师 2 人，是集医疗、教学、科研和专业人才培养于一体的肾脏病诊断和慢性 肾脏病防治中心。近 5 年来，培养了硕士生 20 名,为专业学科的发展培养了高 素质人才。近 5 年发表科研论文 30 余篇，其中 SCI 收录论文 15 篇，获得汕 头市科技进步二等奖 1 项。
The Nephrology always adheres to centering on major clinical scientific problems, which is closely combined with clinical and basic research, focusing on the pathogenesis, comprehensive prevention and treatment and prevention of common kidney diseases. Our research center revolves around the actual situation of kidney diseases in China, where IgA nephropathy, lupus nephritis and peritoneal dialysis are the priority research fields. Furthermore, our center actively carries out epidemiological investigation of chronic kidney disease (CKD) and community intervention against risk factors of CKD, which is an important goal to prevent CKD and reduce the incidence of uremia, and provide scientific basis for the government to prevent and treat CKD.
The Department of Nephrology of the Second Affiliated Hospital of Shantou University Medical College has 1 senior professor, 2 vice senior professors and 2 master instructors, which is a kidney disease diagnosis and chronic kidney disease prevention and treatment center with the integration of medical treatment, teaching, scientific research and professional talent training. So far, 20 master students have been trained in the past five years. In recent 5 years, We have published more than 30 scientific research papers ，and won the municipal class of the second award of scientific and technological advancement.
周添标 Tianbiao Zhou
邮箱及联系电话：zhoutb@aliyun.com, 86-13670402516
Email & Contact Number：zhoutb@aliyun.com, 86-13670402516
研究方向：
1) 干细胞对狼疮性肾炎治疗效果评价；
2) 干细胞对肾小球硬化和肾间质纤维化的治疗作用及机制；
3) 利妥昔单抗对肾小球疾病的治疗作用。 Research Field：
1) Evaluation of therapeutic effect of stem cells on lupus nephritis;
2) Therapeutic effect and mechanism of stem cells on glomerulosclerosis and renal interstitial fibrosis;
3) Rituximab in the treatment of glomerular disease.
导师简介 Biography：
医学博士，主任医师，汕头大学医学院第二附属医院肾内科副主任，广东省中医 药学会肾病专委会常委，汕头市青年英才入选者，汕头大学医学院优秀教师，汕
头大学医学院优秀医师。担任《World Journal of Clinical Cases》(SCI 收录)、
《Journal of Nephrology and Hypertension》《Journal of Nephrology Research and Renal Diseases》等杂志编委。
长期从事肾脏病临床与基础研究，对肾间质纤维化慢性进展发病机制的研究有着 浓厚兴趣，肾间质纤维化发病机制及干细胞在肾脏疾病中的治疗机制是申请者近 年来的工作重点。围绕这一方向，申请者近年来以第一作者/通讯作者身份已发 表 12 篇 SCI 论文。获得广东省自然科学基金和广东科技厅大专项科研基金支持。 课题组目前已使用相应肾小管纤维化动物模型进行的研究已发表 SCI 论文 4 篇。 发表和 MSC 相关 SCI 论文 7 篇（Stem Cell Res Ther 杂志 3 篇，IF=8.079；Stem Cells Int 杂志 3 篇，IF=5.131；Front Cell Dev Biol 杂志 1 篇，IF=6.081）。课题组对肾 脏疾病的临床治疗和发病机制也有一定的研究基础，目前有关乙肝相关肾肾病的 研究成果被美国肾脏病学会 2021 年 Kdigo 指南（肾小球疾病临床实践指南）引 用；有关 HIF-PHI 治疗肾性贫血的研究结果被 2021 年亚太肾病学会 (APSN) 关 于适当使用 HIF-PHI 治疗肾性贫血的指南引用；有关利妥昔单抗治疗肾病研究 结果被 2022 年中华医学会肾脏病学分会专家组制定的指南（利妥昔单抗在肾小 球肾炎中应用的专家共识）引用。目前也在临床中进行推广性应用和验证其有效 性和观察不良反应发生情况。
Doctor of Medicine, Chief Physician, Deputy Director of the Department of Nephrology of the Second Affiliated Hospital of Shantou University School of Medicine, Member of the Standing Committee of the Nephrology Committee of Guangdong Association of Traditional Chinese Medicine, Shantou Young Talent
Candidate, Outstanding Teacher of Shantou University School of Medicine, Outstanding Physician of Shantou University School of Medicine. He is the editorial board member of "World Journal of Clinical Cases" (SCI indexed), "Journal of Nephrology and Hypertension", "Journal of Nephrology Research and Renal Diseases" and other journals.
He has been engaged in the clinical and basic research of renal disease for a long time, and has a strong interest in the research on the pathogenesis of chronic progression of renal interstitial fibrosis. Around this direction, the applicant has published 12 SCI papers as the first author/corresponding author in recent years. It was supported by the Natural Science Foundation of Guangdong Province and the Special Research Fund of Guangdong Science and Technology Department. The research group has published 4 SCI papers using the corresponding renal tubular fibrosis animal models. Published 7 SCI papers related to stem cells (3 in Stem Cell Res Ther, IF=8.079; 3 in Stem Cells Int, IF=5.131; 1 in Front Cell Dev Biol, IF=6.081).
The research group also has a certain research basis for the clinical treatment and pathogenesis of kidney disease. The current research results on hepatitis B-related nephropathy are cited by the American Society of Nephrology's 2021 Kdigo guideline (the clinical practice guideline for glomerular disease). The results of the study related HIF-PHI on the treatment of renal anemia were cited by the 2021 Asia Pacific Society of Nephrology (APSN) guideline on the appropriate use of HIF-PHI for the treatment of renal anemia. The results of the study on the treatment of renal disease with rituximab were cited by the 2022 Chinese Medical Association Nephrology Branch Reference was made to the guidelines developed by the expert group (Expert Consensus on the Use of Rituximab in Glomerulonephritis). At present, it is also being used in clinical promotion to verify its effectiveness and observe the occurrence of adverse reactions.
肾内科 Nephrology
汕头大学医学院第二附属医院肾内科现有正高职称 2 人，副高职称 3 人，硕士 导师 2 人，是集医疗、教学、科研和专业人才培养于一体的肾脏病诊断和慢性 肾脏病防治中心。近 5 年来， 培养了硕士生 20 名,为专业学科的发展培养了 高素质人才。近 5 年发表科研论文 30 余篇，其中 SCI 收录论文 15 篇，获得 汕头市科技进步二等奖 1 项。
The Nephrology always adheres to centering on major clinical scientific problems, which is closely combined with clinical and basic research, focusing on the pathogenesis, comprehensive prevention and treatment and prevention of common kidney diseases. Our research center revolves around the actual situation of kidney diseases in China, where IgA nephropathy, lupus nephritis and peritoneal dialysis are the priority research fields. Furthermore, our center actively carries out epidemiological investigation of chronic kidney disease (CKD) and community6 / 9 intervention against risk factors of CKD, which is an important goal to prevent CKD and reduce the incidence of uremia, and provide scientific basis for the government to prevent and treat CKD.
The Department of Nephrology of the Second Affiliated Hospital of Shantou University Medical College has 2 senior professor, 3 vice senior professors and 2 master instructors, which is a kidney disease diagnosis and chronic kidney disease prevention and treatment center with the integration of medical treatment, teaching, scientific research and professional talent training. So far, 20 master students have been trained in the past five years. In recent 5 years, we have published more than 30 scientific research papers, and won the municipal class of the second award of scientific and technological advancement.
蔡先彬 Xianbin Cai
邮箱及联系电话：cxbin1@qq.com, 86-13592801216
Email & Contact Number：cxbin1@qq.com, 86-13592801216
研究方向：
4) 非酒精性脂肪肝病
5) 粪菌移植
6) 消化系统肿瘤 Research Field：
1) Non-alcoholic fatty liver diseases(NAFLD)
2) Fecal microbiota transplantation
3) Gastrointestinal malignant tumor
导师简介 Biography：
长期从事消化系统疾病的临床和科研工作。在 2013 年到日本兵库医科大学做特 别研究员，2014 年获得国家留学基金委资助攻读该校博士学位。主要研究方向 是：非酒精性脂肪肝病和代谢性相关性疾病（肥胖、代谢综合征, 糖脂代谢）的 发病机制及预防。近年来在免疫代谢调节非酒精性脂肪肝病方面做了相应的研究 工作，主要在炎症细胞、炎症信号通路及炎症分子与胰岛素抵抗的关系方面做了 深入研究。对胰岛素抵抗的病理生理机制有较深理解， 取得相应的研究成果并发 表了相关的 SCI 文章。同时， 开展消化前沿新技术粪菌移植，应用于临床，取得 良好效果；并致力于肠道菌群研究，将基础与临床相结合不断推进微生态领域的 发展，服务于患者。
CLINIACL INTERESTES:
Non-alcoholic fatty liver diseases (NAFLD)
Gastrointestinal malignant tumor
BOARD CERTIFICATIONS
Board member of Guangdong Medical Doctor Association (Gastroenterology)
CLINCLA TITLES
Chief, Divisions: Division of Gastroenterology and Hepatology, The First Affiliated Hospital of Shantou University Medical college.
EDUCATION
1998-2003: Undergraduate student, Shantou University Medical College
2003-2006: Postgraduate student,Shantou University Medical College, Master Degree 2014-2017: Postgraduate student, Hyogo College of Medicine, Japan, Ph.D.
WORKING EXPERIENCES
2006-2009: Resident, The First Affiliated Hospital of Shantou University Medical college
2009-2013: Attending physician, The First Affiliated Hospital of Shantou University Medical college
2013-2020: Associate professor, Division of Gastroenterology and Hepatology, Department of Medicine, The First Affiliated Hospital of Shantou University Medical college
2021-Now: Professor of Medicine, Division of Gastroenterology and Hepatology, The First Affiliated Hospital of Shantou University Medical college
消化病学 Gastroenterology
1.科室介绍：消化内科具有从事消化道疾病临床和基础研究的高素质和稳定的人 员队伍，医疗技术力量雄厚。在科主任荆绪斌教授的带领下， 科室一贯重视对危 重、疑难杂病的诊治工作； 消化科的工作作风一向以严谨科学、认真细致、规范 有序著称，病房的临床工作取得了很大成就。目前我科主要诊治消化系统疾病的 救治，包括消化道出血、肝昏迷、急性胰腺炎、肝衰竭等急症抢救， 及胃、十二 指肠溃疡、胃炎、肠炎、肝炎、肝硬化、消化系统肿瘤等的诊断和治疗。同时也 开展消化前沿新技术——粪菌移植术，应用于肠易激惹综合征、肠道艰难梭菌感 染、炎症性肠病、肝性脑病及慢性便秘腹泻等。医疗水平达到了国内先进水平。
2.科教成果：消化内科是硕士学位的授予点和博士后流动站，现有硕士生导师 4 名。承担包括临床医学专业《诊断学》和《内科学》理论和临床带教任务。在基 础研究方面，消化内科承担着国家自然科学基金、广东省科委、广东省自然科学 基金等众多研究项目，重点对食道、肝癌防治机制， 肠易激综合征、非酒精性脂 肪肝病的发病机制及治疗，肠道微生态（粪菌移植）进行研究，多项成果通过鉴 定，并获省市科技进步奖，并为临床一线治疗提供了可靠的理论基础。
The discipline is a Shantou City Key Clinical Specialty, Regional Center of diagnosis and treatment for Inflammatory bowel disease from IBDQCC, Collaborative Center for Esophageal Diseases from China Health Promotion Foundation. Currently the discipline has 40 beds, Digestive Endoscopy Center of 600 square meters. The number of outpatients from Department of Gastroenterology is 3,500 or so one year. There are 4 people with senior professional titles and 1 with associate professional titles, including the "Famous Doctor of Lingnan Region", "Shantou scientific and technological innovation talents". In the medical teaching and research team, the
proportion of Master Degree and Ph.D. is up to 81% and the teachers have overseas education experiences. Many professors serve as vice chairman of the Shantou Society of Digestive Diseases of Chinese Medical Association.
In the past five years, the discipline has undertaken more than 6 projects supported by the Foundation of National, Province, City, School. Nearly 10 SCI papers have been published. As the main unit to complete the projects, the discipline has won the first prize of Shantou Science and Technology Progress Award twice. The discipline distinguishes itself with the treatment of refractory Gastrointestinal bleeding, liver coma, acute pancreatitis, liver failure, liver cirrhosis, digestive cancer, inflammatory bowel disease. Especially, the cutting-edge new technologies and Fecal Microbiota Transplantation were carried out in our department. So far a number of patients were received gut microbiota reconstruction effectively, including irritable bowel syndrome, inflammatory bowel disease, clostridium difficile infection, hepatic encephalopathy，
chronic functional constipation and functional diarrhea.
俞晶 YuJing
邮箱及联系电话：scorpiojing@139.com，86-13924781267
Email & Contact Number：scorpiojing@139.com ，86-13924781267
研究方向：消化内科及消化内镜方向
Research Field：Gastroenterology and digestive endoscopy direction
导师简介 Biography：
俞晶，消化内科主任医师。现任国家医学考试中心试题开发专家委员会委员、中 国医药教育协会炎症性肠病专业委员会委员、广东省中西医结合学会脾胃消化病 专业委员会常务委员、广东省医学会消化内镜学分会小肠内镜学组成员、广东省 药学会消化专家委员会 IBD 学组核心组员、广东省医师协会肝病专科医师分会 委员、广东省健康管理学会医学营养与健康促进专业委员会炎症性肠病营养治疗 学组委员、海峡两岸医药卫生交流协会消化病学专家委员会青年委员会委员，汕 头市高层次人才，汕头市医学会消化分会委员。
主持、参加省部级及市厅级科研课题 10 项，先后获汕头市科学技术二等奖，广 东省科学技术三等奖各 1 项，近年发表 SCI 收录论文及国内核心期刊学术论文 10 余篇。荣获汕头大学优秀党员、汕头大学医学院优秀党务工作者、汕头大学 医学院第一附属医院最受欢迎带教老师、中华医学会消化病学分会炎症性肠病青 年委员会病例赛全国季军等荣誉称号。
擅长消化系统疾病的诊断和治疗，包括胃炎、炎症性肠病、消化性溃疡、胃食道 反流病、肝炎、肝硬化、胰腺炎、胃肠道肿瘤等，尤其是炎症性肠病（溃疡性结
肠炎和克罗恩病）的诊断和治疗方面。
Yu Jing, Chief Physician of Gastroenterology Department.
Present post: Member of the Expert Committee of Test Question Development of the National Medical Examination Center, Member of the Inflammatory Bowel Disease Professional Committee of China Medical Education Association, Standing Member of the Professional Committee of Spleen and Stomach Digestive Diseases, Guangdong Society of Integrated Traditional Chinese and Western Medicine, Member of the Small Bowel Endoscopy Group of the Digestive Endoscopy Branch of the Guangdong Medical Association, Core member of the IBD group of the Digestive Expert Committee of the Guangdong Pharmaceutical Association, Member of the Hepatology Specialist Branch of Guangdong Medical Doctor Association, Member of the Nutrition Therapy Group of Inflammatory Bowel Disease, Medical Nutrition and Health Promotion Professional Committee of Guangdong Health Management Society, Member of the Youth Committee of the Gastroenterology Expert Committee of the Cross-Strait Medical and Health Exchange Association, High-level talent in Shantou City and the member of Digestive Branch of Shantou Medical Association.
Presided over and participated in 10 scientific research projects at the provincial, ministerial and municipal level, successively won the second prize of Shantou City Science and Technology Award, and the third prize of Guangdong Province Science and Technology Award each. In recent years, he has published more than 10 papers included in SCI and academic papers in domestic core journals. Won the honorary titles of Excellent Party Member of Shantou University, Excellent Party Worker of Shantou University Medical College, the most popular teaching teacher of the First Affiliated Hospital of Shantou University Medical College, and the National Third Runner-up of the Inflammatory Bowel Disease Youth Committee of the Chinese Medical Association Gastroenterology Branch.
Good at diagnosis and treatment of digestive system diseases, including gastritis, inflammatory bowel disease, peptic ulcer, gastroesophageal reflux disease, hepatitis, liver cirrhosis, pancreatitis, gastrointestinal tumors etc., especially inflammatory bowel disease.
消化内科 Gastrointestinal Medicine
消化内科是汕头大学医学院第一附属医院的重点科室，为国家“211工程”重点 建设学科内科学的二级学科，是汕头大学硕士学位的授予点和博士后流动站。有 多名汕头市消化专业学术、技术带头人。专科业务发展方向包括炎症性肠病的早 期诊断与机制研究、肝纤维化、肝硬化门脉高压疾病研究、消化内窥镜的诊断与 治疗和消化道疾病介入技术治疗研究与应用。团队建立了首个粤东 IBD 病区诊 疗小组和专病门诊，建立患者病例数字化档案库、同时建立 IBD 患者微信群、 粤东 IBD 家园公众号。2015 年 1 月团队加入中山大学附属第一医院牵头的广东 IBD 联盟，成为首创联盟成员之一，2017 年 1 月团队加入吴阶平医学基金会中 国炎症性肠病联盟。2017 年团队课题《美沙拉嗪治疗溃疡性结肠炎的有效浓度 分析研究》获广东省医学科研基金立项。2018 年 3 月团队参与完成中华医学会
肠外肠内营养学分会胃肠病与营养协作组《全国多中心炎症性肠病患者营养状况 横断面调查研究（SCRINI）》课题一项。2019 年团队课题《青少年炎症性肠病 患者焦虑抑郁状态及生存质量与临床特征关系的研究》获汕头市科技计划项目立 项。2020 年团队在《International Journal of Immunopathology and Pharmacology》 （JCR2 区，IF: 2.209）发表 1 篇病例报道、2021 年 1 月获评全国炎症性肠病诊 疗区域中心。
Gastroenterology is a key department of the First Affiliated Hospital of Shantou University Medical College. It is a secondary discipline of internal medicine, a key construction discipline of the national "211 Project". It is a post-doctoral mobile station and a master's degree awarding station of Shantou University. The specialty business development direction includes early diagnosis and mechanism research of inflammatory bowel disease, liver fibrosis, liver cirrhosis and portal hypertension disease research, digestive endoscopy diagnosis and treatment, and gastrointestinal disease interventional technology treatment research and application. The team established the first Eastern Guangdong IBD ward diagnosis and treatment team and specialized outpatient clinics, established a digital archive of patient cases, and established a WeChat group for IBD patients, an IBD home official account in Eastern Guangdong. In January 2015, the team joined the Guangdong IBD Alliance led by the First Affiliated Hospital of Sun Yat-sen University and became one of the members of the first alliance. In January 2017, we joined the Wu Jieping Medical Foundation China Inflammatory Bowel Disease Alliance and the team's project "Analysis and Study of the Effective Concentration of Mesalazine in the Treatment of Ulcerative Colitis" was approved by the Guangdong Provincial Medical Research Fund. In March 2018, the team participated in the project of Cross-sectional Research on the Status of Nutrition of Multi-center Inflammatory bowel Diseases (SCRINI) of Gastrointestinal and Nutrition Collaborative Group of Parenteral Nutrition Branch of Chinese Medical Association. In 2019, the team's project “Research on the Relationship between Anxiety and Depression Status, Quality of Life and Clinical Features in Adolescents with Inflammatory Bowel Disease” was approved by the Shantou Science and Technology Project. In 2020, we published a case report in “International Journal of Immunopathology and Pharmacology” (JCR2 area, IF: 2.209), and was awarded the national inflammatory bowel disease diagnosis and treatment regional center in January 2021.